Vassiliki Karantza Selected Research

Adjuvant Chemotherapy

1/2021

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vassiliki Karantza Research Topics

Disease

23	Neoplasms (Cancer) 11/2023 - 01/2010
14	Triple Negative Breast Neoplasms 05/2024 - 01/2010
8	Breast Neoplasms (Breast Cancer) 10/2021 - 06/2010
5	Carcinogenesis 07/2015 - 07/2008
3	Pathologic Complete Response 11/2023 - 01/2020
2	Disease Progression 01/2023 - 01/2020
2	Inflammation (Inflammations) 04/2013 - 06/2010
1	Carcinoma in Situ 11/2023
1	Pancytopenia 01/2021
1	Sepsis (Septicemia) 01/2021
1	Shock 01/2021
1	Neutropenia 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Melanoma (Melanoma, Malignant) 05/2015
1	Critical Illness (Critically Ill) 03/2014
1	Rectal Neoplasms (Rectal Cancer) 03/2014
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Lymphoma (Lymphomas) 01/2012
1	Hyperplasia 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2011
1	Starvation 03/2011

Drug/Important Bio-Agent (IBA)

12	pembrolizumabIBA 05/2024 - 01/2016
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 08/2011
5	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 10/2014 - 06/2010
3	B7-H1 AntigenIBA 05/2024 - 01/2021
3	Gemcitabine FDA Link 01/2022 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2023
2	LigandsIBA 11/2023 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2023 - 04/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2020
2	Epirubicin (Ellence)FDA LinkGeneric 10/2022 - 01/2020
2	Estrogen ReceptorsIBA 10/2021 - 01/2018
2	taxaneIBA 01/2021 - 08/2011
2	human ERBB2 proteinIBA 01/2021 - 07/2015
2	Beclin-1IBA 01/2012 - 06/2010
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Albumin-Bound Paclitaxel FDA Link 01/2022
1	AnthracyclinesIBA 01/2021
1	olaparibIBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	eribulin FDA Link 01/2021
1	130-nm albumin-bound paclitaxelIBA 12/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2016
1	Amino Acids FDA Link 07/2015
1	Riluzole FDA LinkGeneric 05/2015
1	Glutamic Acid (Glutamate)FDA Link 05/2015
1	metabotropic glutamate receptor type 1IBA 05/2015
1	navitoclaxIBA 10/2014
1	Trastuzumab (Herceptin)FDA Link 04/2014
1	Chloroquine (Aralen)FDA LinkGeneric 03/2014
1	Fluorouracil (Carac)FDA LinkGeneric 03/2014
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2014
1	Oxygen (Dioxygen)IBA 06/2012
1	Docetaxel (Taxotere)FDA Link 02/2012
1	Imatinib Mesylate (Gleevec)FDA Link 02/2012
1	Proteasome InhibitorsIBA 08/2011
1	Mitogen-Activated Protein KinasesIBA 08/2011
1	Bortezomib (Velcade)FDA Link 08/2011
1	Bcl-2-Like Protein 11IBA 08/2011
1	Tricarboxylic AcidsIBA 03/2011
1	Keratins (Keratin)IBA 06/2010
1	Keratin-8 (Keratin 8)IBA 06/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2010

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 05/2024 - 06/2012
10	Therapeutics 11/2023 - 07/2008
6	Neoadjuvant Therapy 11/2023 - 01/2020
2	Immunotherapy 01/2021 - 01/2016
1	Adjuvant Chemotherapy 01/2021
1	Critical Care (Surgical Intensive Care) 03/2014
1	Radiotherapy 03/2014